Racial disparities persist in receipt of curative treatment for early-stage non-small cell lung cancer (NSCLC), according to a study published online March 2 in JAMA Network Open. Olivia F. Lynch, MD, ...

Investigators examined the effects of exercise on cancer-related cognitive impairment (CRCI) and mental fatigue in patients receiving chemotherapy in a multicenter phase III randomized controlled ...

No increased risk for thrombosis or bleeding seen with concurrent use of enzalutamide, apalutamide, or abiraterone with DOACs ...

Data show T-DXd improves invasive disease-free survival and reduces the risk of distant recurrence in early HER2-positive breast cancer.

Investigators sought to determine whether complementary and alternative medicine (CAM) affects survival in female patients with breast cancer.

In this study, investigators aimed to explore outcomes following the development of mental health disorders after cancer diagnosis.

The phase 3 SUCCESSOR-2 trial shows mezigdomide-based therapy improves PFS in R/R multiple myeloma patients previously exposed to lenalidomide.

Minnesotan immigrants are facing challenges in accessing healthcare for themselves and their children as ICE prevalence has increased.

Investigators sought to determine whether there were gender disparities in opportunities to present original research at the ASCO Annual Meeting.

The BCG strain Tokyo-172 is noninferior to the commonly used TICE strain for relapse-free survival, which could help to alleviate BCG shortages.

Adding the immune checkpoint inhibitors (ICIs) ipilimumab and nivolumab to percutaneous hepatic perfusion may improve survival outcomes in patients with ...

For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, according to a study ...